Daniel Peterson: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - "*Outbreaks" to "*List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks") |
Notjusttired (talk | contribs) m (Text replacement - "|author-link6=}}" to "}}") |
||
Line 26: | Line 26: | ||
*2001, Neuromyasthenia and [[Chronic Fatigue Syndrome]] (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an [[1984 Incline Village chronic fatigue syndrome outbreak|Outbreak]] <ref>{{Cite journal|last=Strickland|first=Paula S.|last2=Levine|first2=Paul H.|author-link2=Paul Levine|last3=Peterson|first3=Daniel L.|author-link3=Daniel Peterson|last4=O'Brien|first4=Karen|last5=Fears|first5=Thomas|date=Jan 2001|title=Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California|url=http://www.tandfonline.com/doi/full/10.1300/J092v09n03_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=9|issue=3-4|pages=3–14|doi=10.1300/j092v09n03_02|issn=1057-3321|via=}}</ref> [[doi:10.1300/J092v09n03_02|(Abstract)]] | *2001, Neuromyasthenia and [[Chronic Fatigue Syndrome]] (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an [[1984 Incline Village chronic fatigue syndrome outbreak|Outbreak]] <ref>{{Cite journal|last=Strickland|first=Paula S.|last2=Levine|first2=Paul H.|author-link2=Paul Levine|last3=Peterson|first3=Daniel L.|author-link3=Daniel Peterson|last4=O'Brien|first4=Karen|last5=Fears|first5=Thomas|date=Jan 2001|title=Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California|url=http://www.tandfonline.com/doi/full/10.1300/J092v09n03_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=9|issue=3-4|pages=3–14|doi=10.1300/j092v09n03_02|issn=1057-3321|via=}}</ref> [[doi:10.1300/J092v09n03_02|(Abstract)]] | ||
*2003, [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal|last=Carruthers|first=Bruce M.|author-link=Bruce Carruthers|last2=Jain|first2=Anil Kumar|author-link2=Anil Kumar Jain|last3=De Meirleir|first3=Kenny L.|author-link3=Kenny De Meirleir|last4=Peterson|first4=Daniel L.|author-link4=Daniel Peterson|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lerner|first6=A. Martin|author-link6=Martin Lerner|last7=Bested|first7=Alison C.|author-link7=Alison Bested|last8=Flor-Henry|first8=Pierre|author-link8=Pierre Flor-Henry|last9=Joshi|first9=Pradip|author-link9=Pradip Joshi|last10=Powles|first10=A C Peter|author-link10=A C Peter Powles|last11=Sherkey|first11=Jeffrey|author-link11=Jeffrey Sherkey|last12=van de Sande|first12=Marjorie|author-link12=Marjorie van de Sande|date=Jan 2003|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=http://www.tandfonline.com/doi/full/10.1300/J092v11n01_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=11|issue=1|pages=7–115|doi=10.1300/j092v11n01_02|issn=1057-3321|via=}}</ref> [http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf (Full Text)] | *2003, [[Myalgic encephalomyelitis|Myalgic Encephalomyelitis]]/[[Chronic fatigue syndrome|Chronic Fatigue Syndrome]]: Clinical Working Case Definition, Diagnostic and Treatment Protocols<ref>{{Cite journal|last=Carruthers|first=Bruce M.|author-link=Bruce Carruthers|last2=Jain|first2=Anil Kumar|author-link2=Anil Kumar Jain|last3=De Meirleir|first3=Kenny L.|author-link3=Kenny De Meirleir|last4=Peterson|first4=Daniel L.|author-link4=Daniel Peterson|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lerner|first6=A. Martin|author-link6=Martin Lerner|last7=Bested|first7=Alison C.|author-link7=Alison Bested|last8=Flor-Henry|first8=Pierre|author-link8=Pierre Flor-Henry|last9=Joshi|first9=Pradip|author-link9=Pradip Joshi|last10=Powles|first10=A C Peter|author-link10=A C Peter Powles|last11=Sherkey|first11=Jeffrey|author-link11=Jeffrey Sherkey|last12=van de Sande|first12=Marjorie|author-link12=Marjorie van de Sande|date=Jan 2003|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=http://www.tandfonline.com/doi/full/10.1300/J092v11n01_02|journal=Journal of Chronic Fatigue Syndrome|language=en|volume=11|issue=1|pages=7–115|doi=10.1300/j092v11n01_02|issn=1057-3321|via=}}</ref> [http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf (Full Text)] | ||
*2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway<ref>{{Cite journal|last=Suhadolnik|first=Robert J.|author-link=Robert Suhadolnik|last2=Peterson|first2=Daniel L.|author-link2=Daniel Peterson|last3=Reichenbach|first3=Nancy L.|author-link3=|last4=Roen|first4=Gail|author-link4=|last5=Metzger|first5=Melodie|author-link5=|last6=McCahan|first6=John|last7=O'brien|first7=Karen|last8=Welsch|first8=Suzanne|last9=Gabriel|first9=Jerome|last10=Gaughan|first10=John P.|last11= McGregor|first11=Neil R.|author-link11=Neil McGregor|date=2004|title=Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway|url=https://www.tandfonline.com/doi/abs/10.1300/J092v12n01_02|journal=Journal of Chronic Fatigue Syndrome|volume=12|issue=1|pages=5-35|doi=10.1300/J092v12n01_02|quote=|via=|pmc=|pmid=|access-date | *2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway<ref>{{Cite journal|last=Suhadolnik|first=Robert J.|author-link=Robert Suhadolnik|last2=Peterson|first2=Daniel L.|author-link2=Daniel Peterson|last3=Reichenbach|first3=Nancy L.|author-link3=|last4=Roen|first4=Gail|author-link4=|last5=Metzger|first5=Melodie|author-link5=|last6=McCahan|first6=John|last7=O'brien|first7=Karen|last8=Welsch|first8=Suzanne|last9=Gabriel|first9=Jerome|last10=Gaughan|first10=John P.|last11= McGregor|first11=Neil R.|author-link11=Neil McGregor|date=2004|title=Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway|url=https://www.tandfonline.com/doi/abs/10.1300/J092v12n01_02|journal=Journal of Chronic Fatigue Syndrome|volume=12|issue=1|pages=5-35|doi=10.1300/J092v12n01_02|quote=|via=|pmc=|pmid=|access-date=}}</ref> [https://www.researchgate.net/publication/249886680_Clinical_and_Biochemical_Characteristics_Differentiating_Chronic_Fatigue_Syndrome_from_Major_Depression_and_Healthy_Control_Populations (Full Text)] | ||
*2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> [http://mbio.asm.org/content/3/5/e00266-12 (Abstract)] | *2012, A Multicenter Blinded Analysis Indicates No Association between [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] and either [[Xenotropic murine leukemia virus-related virus|Xenotropic Murine Leukemia Virus-Related Virus]] or Polytropic Murine Leukemia Virus<ref name="Alter, et al, 2012" /> [http://mbio.asm.org/content/3/5/e00266-12 (Abstract)] | ||
*2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[Ampligen|rintatolimod]] in severe cases of [[chronic fatigue syndrome]]<ref name="Strayer, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | *2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist [[Ampligen|rintatolimod]] in severe cases of [[chronic fatigue syndrome]]<ref name="Strayer, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448165/ (Full Text)] | ||
Line 38: | Line 38: | ||
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | *2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> [https://academic.oup.com/aje/article/185/8/617/3073694 (Full Text)] | ||
*2017, Immune network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] with atypical and classical presentations<ref name="Hornig, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416687/ (Full Text)] | *2017, Immune network analysis of cerebrospinal fluid in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] with atypical and classical presentations<ref name="Hornig, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5416687/ (Full Text)] | ||
*2018, Decreased Expression of [[TRPM3]] and [[mAChRM3]] in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite journal|last=Marshall-Gradisnik|first=Sonya|author-link=Sonya Marshall-Gradisnik|last2=Fretel|first2=Marshall|last3=Eaton|first3=Natalie|last4=Cabanas|first4=Helene|last5=Balinas|first5=Cassandra|last6=Gopalan|first6=Vinod|last7=Petersen|first7=Daniel|author-link7=Daniel Peterson|last8=Passmore|first8=Rachel|last9=Tang|first9=Kevin|last10= Haque|first10=Mazhar|author-link10=|last11=Lam|first11=Alfred |author-link11=|last12=Staines|first12=Donald|author-link12=Donald Staines|date=2018-05-31|title=Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05|pages=467|doi=10.4236/ijcm.2018.95040|via=|pmc=|pmid=|quote=|author-link2=|access-date=|author-link3=|author-link4=Hélène Cabanas|author-link5 | *2018, Decreased Expression of [[TRPM3]] and [[mAChRM3]] in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref>{{Cite journal|last=Marshall-Gradisnik|first=Sonya|author-link=Sonya Marshall-Gradisnik|last2=Fretel|first2=Marshall|last3=Eaton|first3=Natalie|last4=Cabanas|first4=Helene|last5=Balinas|first5=Cassandra|last6=Gopalan|first6=Vinod|last7=Petersen|first7=Daniel|author-link7=Daniel Peterson|last8=Passmore|first8=Rachel|last9=Tang|first9=Kevin|last10= Haque|first10=Mazhar|author-link10=|last11=Lam|first11=Alfred |author-link11=|last12=Staines|first12=Donald|author-link12=Donald Staines|date=2018-05-31|title=Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis|url=http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05|pages=467|doi=10.4236/ijcm.2018.95040|via=|pmc=|pmid=|quote=|author-link2=|access-date=|author-link3=|author-link4=Hélène Cabanas|author-link5=}}</ref> [http://file.scirp.org/Html/11-2101759_85005.htm (Full text)] | ||
*2018, Insights into [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] phenotypes through comprehensive [[metabolomics]]<ref name="Nagy-Szakal, 2018" /> [https://www.nature.com/articles/s41598-018-28477-9.pdf (Full Text)] | *2018, Insights into [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] phenotypes through comprehensive [[metabolomics]]<ref name="Nagy-Szakal, 2018" /> [https://www.nature.com/articles/s41598-018-28477-9.pdf (Full Text)] | ||
*2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations<ref name="Mandarano2020">{{Cite journal|last=Mandarano|first=Alexandra H.|author-link=|last2=Maya|first2=Jessica|author-link2=|last3=Giloteaux|first3=Ludovic|author-link3=|last4=Peterson|first4=Daniel L.|author-link4=Daniel Peterson|last5=Maynard|first5=Marco|author-link5=|last6=Gottschalk|first6=C. Gunnar|author-link6=|last7=Hanson|first7=Maureen R.|last8=Maureen Hanson|first8=|date=2020-02-10|title=Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations|url=https://www.jci.org/articles/view/132185|journal=Journal of Clinical Investigation|language=en|volume=130|issue=3|pages=1491-1505|doi=10.1172/jci132185|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.jci.org/articles/view/132185 (Full text)] | *2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations<ref name="Mandarano2020">{{Cite journal|last=Mandarano|first=Alexandra H.|author-link=|last2=Maya|first2=Jessica|author-link2=|last3=Giloteaux|first3=Ludovic|author-link3=|last4=Peterson|first4=Daniel L.|author-link4=Daniel Peterson|last5=Maynard|first5=Marco|author-link5=|last6=Gottschalk|first6=C. Gunnar|author-link6=|last7=Hanson|first7=Maureen R.|last8=Maureen Hanson|first8=|date=2020-02-10|title=Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations|url=https://www.jci.org/articles/view/132185|journal=Journal of Clinical Investigation|language=en|volume=130|issue=3|pages=1491-1505|doi=10.1172/jci132185|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.jci.org/articles/view/132185 (Full text)] |
Revision as of 22:02, May 10, 2022
Daniel L. Peterson, MD, is a physician in Incline Village, Nevada specializing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was at the epicenter of the 1984 Incline Village chronic fatigue syndrome outbreak[1] and continues to be a leader in treatment and research about ME/CFS, serving on Simmaron Research’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at Griffith University in Queensland, Australia.[2]
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the Nevada Center for Biomedical Research.[3] He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.[4] In 2019, he joined the scientific advisory board of the Open Medicine Foundation.[5]
Dr. Peterson was the first physician to use Ampligen, an immunomodulator made by AIM ImmunoTech (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on Nancy Kaiser, a very severe patient.[6] He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.[7]
Several documentaries about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have featured Dr. Peterson, including, I Remember Me and Forgotten Plague, and the news feature, Sick and Tired.
Awards[edit | edit source]
- 2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[8]
- 2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by IACFS/ME[8]
Writing committees[edit | edit source]
- 2003, Canadian Consensus Criteria - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[9] (Full Text)
- 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[10]
Notable studies[edit | edit source]
- 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection[11] (Abstract)
- 1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome[12] (Abstract - can request full article)
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen[13] (Abstract)
- 1997, Editorial - Chronic Fatigue Syndrome and Disability[14] (Abstract)
- 2000, Chronic Fatigue Syndrome and Cancer[15] (Abstract)
- 2001, Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an Outbreak [16] (Abstract)
- 2003, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[17] (Full Text)
- 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway[18] (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[19] (Abstract)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[20] (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[21] (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[22] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[23] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[24] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[25] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[26] (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[27] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[28] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[29] (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[30] (Full text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[31] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[32] - (Full text)
Talks and interviews[edit | edit source]
ME/CFS Alert[edit | edit source]
- 2012, Episode 26, ME/CFS Alert interview
- 2013, Episode 50, ME/CFS Alert interview
Invest in ME International ME Conference[edit | edit source]
- 2007, Speaker on Day 1 of the 2nd Invest in ME International ME Conference on Experiences of Research into ME/CFS: Past, Present, and Future - (Video)
- 2007, Speaker on Day 2 of the 2nd Invest in ME International ME Conference on Clinical Research - (Video)
- 2009, Speaker at the 4th Invest in ME International ME Conference on Treatment Regimes for the Most Severe Cases[33] DVD available
- 2012, Speaker at the 7th Invest in ME International ME Conference on Clinical Research Update 2012[34] DVD available
- 2013, Speaker at the 8th Invest in ME International ME Conference on Key Note Speech: The Mainstreaming of ME Research[35] DVD available
Other[edit | edit source]
- 1996, Primetime Live TV Show - Sick and Tired - Incline Village Outbreak[36]
- 2000 Documentary, I Remember Me, directed by Kim A. Snyder[37]
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1
- 2012, Phoenix Rising - Dr Daniel Peterson (July 12)
- 2015, 2015 De osynliga -Seminarium om ME/CFS, Sweden 19 October
- 2017, Solve ME/CFS Initiative’s 2nd Annual Discovery Forum: Presentation by Dr. Dan Peterson
Online presence[edit | edit source]
See also[edit | edit source]
- Ampligen
- Sierra Internal Medicine
- 1984 Incline Village chronic fatigue syndrome outbreak
- Paul Cheney
- List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks
- Canadian Consensus Criteria
Learn more[edit | edit source]
- Wikipedia - Daniel Peterson (physician)
- 1990, Chronic Fatigue Syndrome
- 2019, A Town for People with Chronic Fatigue Syndrome - New Yorker - about Ampligen
References[edit | edit source]
- ↑ "Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising". Health Rising. Retrieved August 13, 2018.
- ↑ "Collaborators - Simmaron Research". Simmaron Research. Retrieved August 13, 2018.
- ↑ "About Us". Nevada Center for Biomedical Research. Retrieved April 13, 2022.
- ↑ "History of Changes for Study: NCT00215813 | Study of Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. April 8, 2010. Retrieved April 13, 2020.
- ↑ "Daniel L. Peterson, MD". Open Medicine Foundation. Retrieved April 1, 2019.
- ↑ "TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS". www.ncf-net.org. Retrieved August 13, 2018.
- ↑ "Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. Retrieved August 13, 2018.
- ↑ 8.0 8.1 "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
- ↑ Buchwald, Dedra; Cheney, Paul R.; Peterson, Daniel L.; Henry, Berch; Wormsley, Susan B.; Geiger, Ann; Ablashi, Dharam V.; Salahuddin, S. Zaki; Saxinger, Carl; Biddle, Royce; Kikinis, Ron; Jolesz, Ferenc A.; Folks, Thomas; Balachandran, N.; Peter, James B.; Gallo, Robert C.; Komaroff, Anthony L. (1992), "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection", Annals of Internal Medicine, 116 (2): 103-113, PMID 1309285
- ↑ Levine, Paul H.; Jacobson, Steven; Pocinki, Alan G.; Cheney, Paul; Peterson, Daniel; Connelly, Roger R; Weil, R; Robinson, SM; Ablashi, Dharam V; Salahuddin, Sayeef Z; Pearson, GR; Hoover, R (1992), "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome", Archives of Internal Medicine, 152 (8): 1611-1616, doi:10.1001/archinte.1992.00400200049009
- ↑ Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53, doi:10.1300/J092v01n01_04
- ↑ Peterson, Daniel L. (January 1997). "Chronic Fatigue Syndrome and Disability". Journal of Chronic Fatigue Syndrome. 3 (4): 5–7. doi:10.1300/j092v03n04_02. ISSN 1057-3321.
- ↑ Levine, Paul H.; Pilkington, Deborah; Strickland, Paula; Peterson, Daniel (2000), "Chronic Fatigue Syndrome and Cancer", Journal of Chronic Fatigue Syndrome, 7 (1): 29-38, doi:10.1300/J092v07n01_04
- ↑ Strickland, Paula S.; Levine, Paul H.; Peterson, Daniel L.; O'Brien, Karen; Fears, Thomas (January 2001). "Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California". Journal of Chronic Fatigue Syndrome. 9 (3–4): 3–14. doi:10.1300/j092v09n03_02. ISSN 1057-3321.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Suhadolnik, Robert J.; Peterson, Daniel L.; Reichenbach, Nancy L.; Roen, Gail; Metzger, Melodie; McCahan, John; O'brien, Karen; Welsch, Suzanne; Gabriel, Jerome; Gaughan, John P.; McGregor, Neil R. (2004). "Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway". Journal of Chronic Fatigue Syndrome. 12 (1): 5–35. doi:10.1300/J092v12n01_02.
- ↑ Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, SB; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Hornig, M; Gottschalk, G; Peterson, D; Knox, KK; Schultz, AF; Eddy, ML; Che, X; Lipkin, WI (2016), "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.", Molecular Psychiatry, 21 (2): 261-9, doi:10.1038/mp.2015.29
- ↑ Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Hornig, M; Gottschalk, G; Eddy, ML; Che, X; Ukaigwe, JE; Peterson, DL; Lipkin, WI (2017), "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations", Translational Psychiatry, 7 (4), doi:10.1038/tp.2017.44
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ Nagy-Szakal, Dorottya; Barupal, Dinesh K.; Lee, Bohyun; Che, Xiaoyu; Williams, Brent L.; Kahn, Ellie J. R.; Ukaigwe, Joy E.; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Levin, Bruce; Hornig, Mady; Fiehn, Oliver; Lipkin, W. Ian (2018), "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics", Scientific Reports, 8 (1): 10056, doi:10.1038/s41598-018-28477-9
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R.; Maureen Hanson (February 10, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/jci132185.
- ↑ "Invest in ME Research - IIMEC4". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC7 International ME Conference 2012". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC8 International ME Conference 2013". Invest in ME Research. Retrieved February 4, 2020.
- ↑ CFS and the CDC's Failure to Respond: Primetime Live (1996), retrieved February 4, 2020
- ↑ I Remember Me, retrieved February 4, 2020